Thursday, September 12, 2019 2:42:15 PM
Did they pass the FDA?
Recent ARDX News
- Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings • GlobeNewswire Inc. • 04/27/2026 12:01:00 PM
- Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 • GlobeNewswire Inc. • 04/23/2026 12:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 08:04:27 PM
- Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 • GlobeNewswire Inc. • 04/16/2026 12:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:16:22 PM
- Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx • GlobeNewswire Inc. • 04/01/2026 12:01:00 PM
- Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award • GlobeNewswire Inc. • 03/12/2026 12:00:00 PM
- Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Ardelyx to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:47:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:45:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:45:03 AM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 02/23/2026 11:17:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2026 12:18:49 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:57:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:35:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:21:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:07:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 10:48:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 10:18:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:03:51 PM
- Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/19/2026 09:01:00 PM
- Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
